NICE, which serves as a cost-effectiveness agency has said in a draft guidance that it supports the use of Xtandi (enzalutamide) in men whose prostate cancer has spread after the failure of first-line therapy (i.e. ADT), but for whom chemotherapy is not yet necessary. The agency found that Xtandi can delay the need for chemotherapy, [...]
As we reach this holiday season I want to remind you that Malecare has been working to help you and your family survive longer and have a better quality of life. We have helped you in ways that you are aware of; like through this blog and by the Malecare Advanced Prostate Cancer Online Support Group. [...]
We have some good news, the United States Congress has passed the Omnibus spending package. The package will fund the U.S. Government through fiscal 2016. We should take note that this bill includes a $2 billion increase for the National Institute of Health (NIH), a 5% increase for the National Cancer Institute (NCI) and the [...]
There has been a lot of buzz around the new scanning contrasts that have come into limited usage for evaluating metastasized cancer cells that are in the bones. Despite the enthusiasm from the prostate and breast cancer communities, CMS (Medicare) continues to limit its financial coverage for PET scans using the contrast NaF-18 even though [...]
The US Congress has just published the proposed Omnibus Budget for 2016. The good news is that the proposed budget includes the restoration of the 13.2 million dollars to the Centers for Disease Control (CDC) for Prostate Cancer Prevention and Education and it also includes 80 million dollars for the Department of Defense Prostate Cancer [...]
Currently, there are a number of different treatments used to treat recurrent prostate cancer when the primary treatment had radiation has failed. In this situation surgery is considered very difficult and can only be successfully performed by an experienced surgeon, so alternative treatments are often considered. Long-term data about the success of these alternative treatments [...]
A story written by Dominic Horsley and published in the Yorkshire Evening Post claims that in May a 41 year old prostate cancer survivor from Woodlesford was referred to specialists at Leeds St James’s Hospital. He claimed that he had aches in his lower body but says t consultants told him that he was told [...]
Many cancer treatments have the potential to impact your overall quality of life (QoL). Before making any decision to use a treatment it is important to understand what might be the possible impacts of the treatment not only on the disease, but also on your life. Impacts could be positive or they could be negative. [...]
I have talked a lot about our need to take the next step in clinical care, understanding the best sequencing of our drugs. Since we have a number of new drugs to treat advanced prostate cancer we now need to better understand which drugs should be used in which men as well as their proper [...]
Can exercise improve the quality of life of men with advanced prostate cancer and also extend their survival? To help answer this question a major new global trial known as GAP4 has been launched in Dublin, Ireland. The trial has a goal of recruiting 866 men from seven countries, including Ireland. The trial will be [...]
